ASEAN CSDT Dossier for Pakistan Registration

1. Key takeaways

Pakistan does not mandate the ASEAN Common Submission Dossier Template (CSDT) anywhere in its rules. The country’s dossier requirements are framed as “the information specified in the form” (Form-6A or Form-7A) rather than as “organised according to the CSDT”. However, because Pakistan operates a reference regulatory authority reliance mechanism (Rule 15(2)) and requires technical documentation in English, organising the technical dossier along CSDT lines is in practice both workable and efficient. The correct positioning of the CSDT in Pakistan is therefore that of an organisational tool, not a statutory format. Teams that understand this distinction gain the reuse benefits of a common template without mistaking the template for a legal obligation, and teams that misunderstand it either waste effort or, worse, present the CSDT to the regulator as if compliance with it were the test.

• Pakistan’s dossier content requirement is anchored in the statutory forms, not in the CSDT.
• The reliance mechanism of Rule 15(2) and the English-language documentation expectation make a CSDT-style structure a practical fit.
• The CSDT is an organising instrument; the acceptance test remains the form itself.
• CSDT organisation enables direct reuse of reference-country approval evidence compiled to an internationally recognised structure.
• A cross-reference table between CSDT sections and form fields keeps reviewers oriented.
• The practical consequence is a single decision point made early: choose the form as the binding skeleton, and let the CSDT shape only what sits inside the technical file.
• Treating the CSDT correctly also disciplines expectations in the other direction, since nothing in the Pakistani rules exempts an applicant from any field of the statutory form.

2. Legal basis

The statutory anchors below come from the Medical Devices Rules 2017, notified on 16 January 2018. None of them names the CSDT; each instead shapes the dossier around the form, reliance, consistency and verification, which is precisely why the CSDT can serve as an internal structure without ever becoming the compliance benchmark. Reading the table in sequence, the rule set first fixes what must be submitted, then opens the door to reliance on reference-country evidence, then ties the label to the approved version, and finally subjects manufacturing and testing to the principles of verification. The CSDT sits comfortably inside all four because it was designed to carry exactly this kind of evidence.

3. Expert insights

Insight one: Vietnam mandates the CSDT and Pakistan does not, and these are two very different situations hidden behind the same three letters. Vietnam imposes the CSDT on Class C and Class D submissions; the Pakistani rules contain no such wording. Transplanting one country’s mandatory requirement onto another country is the single most common error found in Chinese-language source material on this topic. The consequence of the error is real either way: a team that believes CSDT is mandatory in Pakistan over-engineers its submission and frightens itself with imagined constraints, while a team that believes no structure is expected anywhere loses the opportunity to reuse materials that were already written to a common template.

Insight two: the value of the CSDT in Pakistan is reuse, not compliance. Reference-country approval evidence, such as FDA 510(k) clearances or CE certificates under the EU MDR, is by its nature usually compiled to an internationally familiar structure. Organising the Pakistan technical file along CSDT chapters allows that existing material to be lifted across directly, reducing the effort of re-arranging documents into a new order for a single market. The benefit compounds when a portfolio is registered in multiple markets, because one internally consistent technical file can serve several regulators with only the outer wrapper changing.

Insight three: the skeleton that is actually submitted must be Form-6A or Form-7A. The CSDT may serve as the internal structure of the technical documentation, but the format on which acceptance turns is the statutory form itself. The recommended working method is to build a cross-reference table that maps each CSDT chapter to the corresponding field of the form, so that a reviewing officer can move from any field of the form to the supporting section without searching. The template then does its job silently, and the form does its job visibly.

A closing observation ties the three insights together. The reason the CSDT works so naturally in Pakistan is that the two mechanisms it exploits, reliance on reference regulators and English-language documentation, both reward material that already speaks the international idiom. A dossier that was first assembled for a reference market, and then organised along CSDT lines, arrives in Pakistan already dressed for the occasion; a dossier written from scratch to a purely local pattern arrives underdressed. The tool is optional, but the fit is not accidental, and recognising why it fits is what turns a template from a habit into a strategy.

4. Practical recommendations

• Adopt a two-layer dossier structure for Pakistan: bind the outer layer in the field order of Form-6A or Form-7A so that acceptance requirements are satisfied exactly as written.
• Compile the inner layer of technical documentation along CSDT chapters, preserving the structure for reuse across markets.
• Attach a cross-reference table between the two layers, mapping every CSDT section to the form field it supports.
• Use this arrangement so that one set of materials can simultaneously serve Pakistan and markets such as Vietnam and Malaysia, instead of building a separate file for each.
• Re-examine the mapping whenever a form version or a CSDT revision changes, so the cross-reference never drifts out of date.

5. Verification checklist

• □ Confirmed that the CSDT is not a legally mandatory format in Pakistan
• □ Outer dossier bound in the field order of Form-6A / Form-7A
• □ Inner technical documentation compiled along CSDT chapters
• □ Cross-reference table between CSDT sections and form fields attached
• □ Feasibility of cross-market reuse assessed

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Pakistan. Our team prepares dossiers to DRAP expectations, manages eCTD-format submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com